药物新剂型与新技术

1.MiR-223 promotes the doxorubicin resistance of colorectal cancer cells via regulating epithelial-mesenchymal transition by targeting FBXW7 , ActaBiochimica et Biophysica Sinica, 2018.06, 50(6): 597~604 2.Conjugation magnetic PAEEP-PLLA nanoparticles with lactoferrin as a specific targeting MRI contrast agent for detection of brain glioma in rats. Nanoscal Research Letters, 2016.11.227 3.Novel DiR and SPIO nanoparticles embedded PEG-PLGA nanobubbles as a multimodal imaging contrast agent. Bio-Medical Materials and Engineering, 2015, 10，S911-916 4.Novel lactoferrin-conjugated amphiphilic poly(aminoethyl ethylene phosphate)/poly(L-lactide) copolymer nanobubbles for tumor targeting ultrasonic imaging. International Journal of Nanomedicine,2015,10,5805-5817 5.Novel lactoferrin-conjugated PAEEP-PLLA copolymer nanobubbles as contrast agents for tumor targeting ultrasonic imaging. Chinese Pharmaceutical Conference, 2015.9.